263 related articles for article (PubMed ID: 37502435)
1. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.
He Q; Mao C; Chen Z; Zeng Y; Deng Y; Hu R
Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493
[TBL] [Abstract][Full Text] [Related]
3. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Cai XJ; Wang L; Hu CM
J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
Viramontes Hörner D; Avery A; Stow R
J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Butterworth RF; Kircheis G; Hilger N; McPhail MJW
J Clin Exp Hepatol; 2018 Sep; 8(3):301-313. PubMed ID: 30302048
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
Hammd M; Elghezewi A; Abdulhadi A; Alabid A; Alabid A; Badi Y; Kamal I; Hesham Gamal M; Mohamed Fisal K; Mujtaba M; Sherif A; Frandah W
Cureus; 2024 Jan; 16(1):e53341. PubMed ID: 38435950
[TBL] [Abstract][Full Text] [Related]
9. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
[TBL] [Abstract][Full Text] [Related]
11. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
12. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for patients with hepatic encephalopathy.
McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
[TBL] [Abstract][Full Text] [Related]
14. Minimal hepatic encephalopathy.
Dhiman RK; Chawla YK
Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
Dhiman RK; Thumburu KK; Verma N; Chopra M; Rathi S; Dutta U; Singal AK; Taneja S; Duseja A; Singh M
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):800-812.e25. PubMed ID: 31476436
[TBL] [Abstract][Full Text] [Related]
16. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial.
Pratap Mouli V; Benjamin J; Bhushan Singh M; Mani K; Garg SK; Saraya A; Joshi YK
Hepatol Res; 2015 Aug; 45(8):880-9. PubMed ID: 25266207
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for people with hepatic encephalopathy.
Dalal R; McGee RG; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908
[TBL] [Abstract][Full Text] [Related]
18. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
19. L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
Butterworth RF; McPhail MJW
Drugs; 2019 Feb; 79(Suppl 1):31-37. PubMed ID: 30706425
[TBL] [Abstract][Full Text] [Related]
20. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
